Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XLJDOD in Stage IIIB/IIIC Colon Cancer
NCT05709249Phase 3Recruiting
- Sponsor
- Jiangsu Famous Medical Technology
- Start
- Dec 2022
- Primary completion
- Apr 2027
- Modality
- HM (Herbal Medicine), CHG (Compound herbal granule), NPI (Non-pharmacological intervention)
- Countries
- 1
01
Overview
A Phase 3 trial of Xian-Lian-Jie-Du Optimization Decoction in colon cancer, sponsored by Jiangsu Famous Medical Technology. Started Dec 2022; status: recruiting.
02
Drugs
Xian-Lian-Jie-Du Optimization Decoction
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT05709249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05709249.